Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characteristics of chronic lymphocytic leukemia in Japan: Comprehensive analysis of the CLLRSG-01 study. | Int J Hematol | 2024 | 38492198 | PubTator, text mining | PubMed |
| Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming. | NPJ Vaccines | 2024 | 38467663 | PubTator, text mining | PubMed |
| Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia. | Ann Hematol | 2024 | 38308707 | PubTator, text mining | PubMed |
| Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort. | Hematol Oncol | 2024 | 38287529 | PubTator, text mining | PubMed |
| Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates. | Cancer Immunol Immunother | 2024 | 38280019 | PubTator, text mining | PubMed |
| What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study. | Cancers (Basel) | 2024 | 38275909 | PubTator, text mining | PubMed |
| Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus. | Commun Biol | 2024 | 38267569 | PubTator, text mining | PubMed |
| Expression Pattern and Prognostic Significance of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2024 | 38255996 | PubTator, text mining | PubMed |
| Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. | Ann Hematol | 2024 | 38236391 | PubTator, text mining | PubMed |
| Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. | Blood | 2024 | 38215395 | PubTator, text mining | PubMed |
| Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing. | Clin Chem | 2024 | 38175592 | PubTator, text mining | PubMed |
| ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV-unmutated chronic lymphocytic leukemia. | Blood Adv | 2024 | 38113463 | PubTator, text mining | PubMed |
| Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial. | Nat Med | 2024 | 38071379 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals diverse B cell phenotypes in patients with anti-NMDAR encephalitis. | Psychiatry Clin Neurosci | 2024 | 38063052 | PubTator, text mining | PubMed |
| Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation. | J Pathol Clin Res | 2024 | 37987115 | PubTator, text mining | PubMed |
| Frontline Therapy in Chronic Lymphocytic Leukemia. | Acta Haematol | 2024 | 37899041 | PubTator, text mining | PubMed |
| Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia. | Blood Adv | 2024 | 37871300 | PubTator, text mining | PubMed |
| Development and Validation of Serum Markers as Noninvasive Diagnostic Methods for Achalasia. | Clin Transl Gastroenterol | 2024 | 37787436 | PubTator, text mining | PubMed |
| Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. | Hematol Oncol | 2024 | 37772620 | PubTator, text mining | PubMed |
| Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes. | Haematologica | 2024 | 37706332 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=11